Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y)

Xinliang Zhou; Xinyi Men; Riyang Zhao; Jing Han; Zhisong Fan; Yudong Wang; Yalei Lv; Jing Zuo; Lianmei Zhao; Meixiang Sang; Xian De Liu; Baoen Shan

doi:10.1038/s41417-020-00241-0

Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y)

Xinliang Zhou, Xinyi Men, Riyang Zhao, Jing Han, Zhisong Fan, Yudong Wang, Yalei Lv, Jing Zuo, Lianmei Zhao, Meixiang Sang, Xian De Liu, Baoen Shan

Genitourinary Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

The original version of this Article contained inaccuracies in Figs. 2a and 4d (one micrograph has been duplicated and presented as something else), Figs. 2b and 4c (one micrograph has been duplicated and presented as something else) and Figs. 3b and 4j (the two beta-actin bands are more similar than you would expect). All figures have been corrected in both the PDF and HTML versions of the Article. Figure 4d: A large number of wound-healing assays graphs were taken, and had been taken as the cell control for the NCI-N87 (NCI-N87 and NCI-N87 NC), however there was negligence and repetition in the naming of the pictures. Therefore, these eventually led to the wrong insertion of the image when the authors prepared the figures. One image was repeated in Fig. 2a and Fig. 4d. Figure 4d has been corrected.

Original language	English (US)
Pages (from-to)	976-978
Number of pages	3
Journal	Cancer gene therapy
Volume	27
Issue number	12
DOIs	https://doi.org/10.1038/s41417-020-00241-0
State	Published - Dec 2020

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Cancer Research

Access to Document

10.1038/s41417-020-00241-0

Cite this

Zhou, X., Men, X., Zhao, R., Han, J., Fan, Z., Wang, Y., Lv, Y., Zuo, J., Zhao, L., Sang, M., Liu, X. D., & Shan, B. (2020). Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y). Cancer gene therapy, 27(12), 976-978. https://doi.org/10.1038/s41417-020-00241-0

Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y). / Zhou, Xinliang; Men, Xinyi; Zhao, Riyang et al.
In: Cancer gene therapy, Vol. 27, No. 12, 12.2020, p. 976-978.

Research output: Contribution to journal › Comment/debate › peer-review

Zhou, X, Men, X, Zhao, R, Han, J, Fan, Z, Wang, Y, Lv, Y, Zuo, J, Zhao, L, Sang, M, Liu, XD & Shan, B 2020, 'Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y)', Cancer gene therapy, vol. 27, no. 12, pp. 976-978. https://doi.org/10.1038/s41417-020-00241-0

@article{bd01d40929d446ba846780081a011175,

title = "Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y)",

abstract = "The original version of this Article contained inaccuracies in Figs. 2a and 4d (one micrograph has been duplicated and presented as something else), Figs. 2b and 4c (one micrograph has been duplicated and presented as something else) and Figs. 3b and 4j (the two beta-actin bands are more similar than you would expect). All figures have been corrected in both the PDF and HTML versions of the Article. Figure 4d: A large number of wound-healing assays graphs were taken, and had been taken as the cell control for the NCI-N87 (NCI-N87 and NCI-N87 NC), however there was negligence and repetition in the naming of the pictures. Therefore, these eventually led to the wrong insertion of the image when the authors prepared the figures. One image was repeated in Fig. 2a and Fig. 4d. Figure 4d has been corrected.",

author = "Xinliang Zhou and Xinyi Men and Riyang Zhao and Jing Han and Zhisong Fan and Yudong Wang and Yalei Lv and Jing Zuo and Lianmei Zhao and Meixiang Sang and Liu, {Xian De} and Baoen Shan",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2020",

month = dec,

doi = "10.1038/s41417-020-00241-0",

language = "English (US)",

volume = "27",

pages = "976--978",

journal = "Cancer gene therapy",

issn = "0929-1903",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Correction

T2 - miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y)

AU - Zhou, Xinliang

AU - Men, Xinyi

AU - Zhao, Riyang

AU - Han, Jing

AU - Fan, Zhisong

AU - Wang, Yudong

AU - Lv, Yalei

AU - Zuo, Jing

AU - Zhao, Lianmei

AU - Sang, Meixiang

AU - Liu, Xian De

AU - Shan, Baoen

PY - 2020/12

Y1 - 2020/12

N2 - The original version of this Article contained inaccuracies in Figs. 2a and 4d (one micrograph has been duplicated and presented as something else), Figs. 2b and 4c (one micrograph has been duplicated and presented as something else) and Figs. 3b and 4j (the two beta-actin bands are more similar than you would expect). All figures have been corrected in both the PDF and HTML versions of the Article. Figure 4d: A large number of wound-healing assays graphs were taken, and had been taken as the cell control for the NCI-N87 (NCI-N87 and NCI-N87 NC), however there was negligence and repetition in the naming of the pictures. Therefore, these eventually led to the wrong insertion of the image when the authors prepared the figures. One image was repeated in Fig. 2a and Fig. 4d. Figure 4d has been corrected.

AB - The original version of this Article contained inaccuracies in Figs. 2a and 4d (one micrograph has been duplicated and presented as something else), Figs. 2b and 4c (one micrograph has been duplicated and presented as something else) and Figs. 3b and 4j (the two beta-actin bands are more similar than you would expect). All figures have been corrected in both the PDF and HTML versions of the Article. Figure 4d: A large number of wound-healing assays graphs were taken, and had been taken as the cell control for the NCI-N87 (NCI-N87 and NCI-N87 NC), however there was negligence and repetition in the naming of the pictures. Therefore, these eventually led to the wrong insertion of the image when the authors prepared the figures. One image was repeated in Fig. 2a and Fig. 4d. Figure 4d has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85095123149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095123149&partnerID=8YFLogxK

U2 - 10.1038/s41417-020-00241-0

DO - 10.1038/s41417-020-00241-0

M3 - Comment/debate

C2 - 33154576

AN - SCOPUS:85095123149

SN - 0929-1903

VL - 27

SP - 976

EP - 978

JO - Cancer gene therapy

JF - Cancer gene therapy

IS - 12

ER -

Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (Cancer Gene Therapy, (2018), 25, 3-4, (68-76), 10.1038/s41417-017-0005-y)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this